Clinical Trial Update: A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis [NA]

View source ↗

Summary

Clinical trial evaluating preventive dosing of fondaparinux vs placebo for preventing venous thromboembolism in patients undergoing coronary bypass surgery; stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Bypass Surgery
• Deep Vein Thrombosis
• Venous Thromboembolism

Drugs mentioned

• Fondaparinux (fondaparinux)

Snippet

Sponsor: Prairie Education and Research Cooperative | Conditions: Deep Vein Thrombosis, Coronary Artery Bypass Surgery | NA | Status: TERMINATED | Results posted: 2022-09-08